Clinical Trial

Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Patients

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated February 17, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to evaluate the efficacy and Safety after conversion to RaparoBell® or Myrept® in patients who in renal transplant patients undergoing maintenance therapy with Mycophenolic acid.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-01-03; most recent amendment 2026-02-12.
Status change: Recruiting → Active, Not Recruiting 2026-02-12
Trial Details
NCT Number NCT05193565
Lead Sponsor Chong Kun Dang Pharmaceutical
Conditions Kidney Transplantation
Enrollment 206 participants
Start Date 2021-11-19
Primary Completion 2026-07 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2026-02-17